Published in Obesity and Diabetes Week, December 20th, 2004
Revenues in the quarter were $2.400 billion, an increase of 11% over the $2.164 billion of the comparable period 1 year ago. Reflecting the weaker dollar, foreign currency translation had a positive impact on quarterly revenue of $40.0 million when compared to last year.
"Financial performance this quarter was once again led by two of Medtronic's largest product lines, spinal products and implantable...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week